These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29721395)

  • 1. Super-charged NK cells inhibit growth and progression of stem-like/poorly differentiated oral tumors
    Kaur K; Topchyan P; Kozlowska AK; Ohanian N; Chiang J; Maung PO; Park SH; Ko MW; Fang C; Nishimura I; Jewett A
    Oncoimmunology; 2018; 7(5):e1426518. PubMed ID: 29721395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotic-Treated Super-Charged NK Cells Efficiently Clear Poorly Differentiated Pancreatic Tumors in Hu-BLT Mice.
    Kaur K; Kozlowska AK; Topchyan P; Ko MW; Ohanian N; Chiang J; Cook J; Maung PO; Park SH; Cacalano N; Fang C; Jewett A
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31878338
    [No Abstract]   [Full Text] [Related]  

  • 3. NK cells shape pancreatic and oral tumor microenvironments; role in inhibition of tumor growth and metastasis.
    Jewett A; Kos J; Fong Y; Ko MW; Safaei T; Perišić Nanut M; Kaur K
    Semin Cancer Biol; 2018 Dec; 53():178-188. PubMed ID: 30081230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Tumor Growth and Differentiation in NSG and Humanized-BLT Mice; Analysis of Human vs. Humanized-BLT-Derived NK Expansion and Functions.
    Kaur K; Jewett A
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential therapy with supercharged NK cells with either chemotherapy drug cisplatin or anti-PD-1 antibody decreases the tumor size and significantly enhances the NK function in Hu-BLT mice.
    Kaur K; Chen PC; Ko MW; Mei A; Senjor E; Malarkannan S; Kos J; Jewett A
    Front Immunol; 2023; 14():1132807. PubMed ID: 37197660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of Gingival NK Cells in Precancerous and Cancerous Stages of Pancreatic Cancer in KC and BLT-Humanized Mice.
    Kaur K; Chang HH; Cook J; Eibl G; Jewett A
    Front Immunol; 2017; 8():1606. PubMed ID: 29255459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADCC against MICA/B Is Mediated against Differentiated Oral and Pancreatic and Not Stem-Like/Poorly Differentiated Tumors by the NK Cells; Loss in Cancer Patients due to Down-Modulation of CD16 Receptor.
    Kaur K; Safaie T; Ko MW; Wang Y; Jewett A
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33440654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice.
    Kozlowska AK; Kaur K; Topchyan P; Jewett A
    Cancer Immunol Immunother; 2016 Jul; 65(7):835-45. PubMed ID: 27034236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Strategy to Expand Super-Charged NK Cells with Significant Potential to Lyse and Differentiate Cancer Stem Cells: Differences in NK Expansion and Function between Healthy and Cancer Patients.
    Kaur K; Cook J; Park SH; Topchyan P; Kozlowska A; Ohanian N; Fang C; Nishimura I; Jewett A
    Front Immunol; 2017; 8():297. PubMed ID: 28424683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel strategies to target cancer stem cells by NK cells; studies in humanized mice.
    Kozlowska AK; Kaur K; Topchyan P; Jewett A
    Front Biosci (Landmark Ed); 2017 Jan; 22(2):370-384. PubMed ID: 27814619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmented IFN-γ and TNF-α Induced by Probiotic Bacteria in NK Cells Mediate Differentiation of Stem-Like Tumors Leading to Inhibition of Tumor Growth and Reduction in Inflammatory Cytokine Release; Regulation by IL-10.
    Bui VT; Tseng HC; Kozlowska A; Maung PO; Kaur K; Topchyan P; Jewett A
    Front Immunol; 2015; 6():576. PubMed ID: 26697005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural Killer Cells: Diverse Functions in Tumor Immunity and Defects in Pre-neoplastic and Neoplastic Stages of Tumorigenesis.
    Jewett A; Kos J; Kaur K; Safaei T; Sutanto C; Chen W; Wong P; Namagerdi AK; Fang C; Fong Y; Ko MW
    Mol Ther Oncolytics; 2020 Mar; 16():41-52. PubMed ID: 31930165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of Split Anergy Conditions Natural Killer Cells to Promote Differentiation of Stem Cells through Cell-Cell Contact and Secreted Factors.
    Tseng HC; Bui V; Man YG; Cacalano N; Jewett A
    Front Immunol; 2014; 5():269. PubMed ID: 24995006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells.
    Kozlowska AK; Tseng HC; Kaur K; Topchyan P; Inagaki A; Bui VT; Kasahara N; Cacalano N; Jewett A
    Cancer Immunol Immunother; 2016 Sep; 65(9):1085-97. PubMed ID: 27439500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple Defects of Natural Killer Cells in Cancer Patients: Anarchy, Dysregulated Systemic Immunity, and Immunosuppression in Metastatic Cancer.
    Jewett A; Kos J; Kaur K; Turnsek TL; Breznik B; Senjor E; Wong P; Nguyen KY; Ko MW
    Crit Rev Immunol; 2020; 40(2):93-133. PubMed ID: 32749091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective Patient NK Function Is Reversed by AJ2 Probiotic Bacteria or Addition of Allogeneic Healthy Monocytes.
    Ko MW; Kaur K; Safaei T; Chen W; Sutanto C; Wong P; Jewett A
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supercharged NK Cell-Based Immuotherapy in Humanized Bone Marrow Liver and Thymus (Hu-BLT) Mice Model of Oral, Pancreatic, Glioblastoma, Hepatic, Melanoma and Ovarian Cancers.
    Kaur K; Jewett A
    Crit Rev Immunol; 2023; 43(2):13-25. PubMed ID: 37938193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Split anergized Natural Killer cells halt inflammation by inducing stem cell differentiation, resistance to NK cell cytotoxicity and prevention of cytokine and chemokine secretion.
    Tseng HC; Cacalano N; Jewett A
    Oncotarget; 2015 Apr; 6(11):8947-59. PubMed ID: 25860927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation by NK cells is a prerequisite for effective targeting of cancer stem cells/poorly differentiated tumors by chemopreventive and chemotherapeutic drugs.
    Kozlowska AK; Topchyan P; Kaur K; Tseng HC; Teruel A; Hiraga T; Jewett A
    J Cancer; 2017; 8(4):537-554. PubMed ID: 28367234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells target and differentiate cancer stem-like cells/undifferentiated tumors: strategies to optimize their growth and expansion for effective cancer immunotherapy.
    Kaur K; Nanut MP; Ko MW; Safaie T; Kos J; Jewett A
    Curr Opin Immunol; 2018 Apr; 51():170-180. PubMed ID: 29653339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.